Charts Omnicell, Inc. Deutsche Boerse AG
Stocks
OC9
US68213N1090
Advanced Medical Equipment & Technology
|
Real-time Estimate
Tradegate
01:30:33 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 28.20 EUR | +1.44% |
|
-0.71% | -28.35% |
| 09-03 | Tracelink, Inc. and Omnicell, Inc. Integrate Dscsa Compliance Solution into Hospital Pharmacy Operations | CI |
| 08-14 | US Physical Therapy Names Nchacha Etta as Chief Financial Officer | MT |
Chart: Technical Analysis
Deutsche Boerse AGEUR
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OMCL | Delayed | |
CBOE
| OMCL | Real-time | |
Deutsche Boerse AG
| OC9 | Delayed | |
Börse Stuttgart
| OC9 | Delayed | |
Tradegate
| OC9 | Real-time | |
Boerse Muenchen
| OC9 | Real-time | |
Berne S.E.
| OC9 | End-of-day quote |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- OMCL Stock
- OC9 Stock
- Charts Omnicell, Inc.
Select your edition
All financial news and data tailored to specific country editions

















